{
  "updated_at": "2026-02-06T02:53:14.548Z",
  "total": 6,
  "documents": [
    {
      "id": "ctgov:EXAMPLE-OA-001",
      "source": "clinicaltrials",
      "url": "https://clinicaltrials.gov/study/NCT00000001",
      "title": "Example OA trial (illustrative)",
      "authors": "",
      "date": "2025-01-10",
      "abstract_or_snippet": "Illustrative terminated trial for OA endpoints.",
      "doc_type": "trial",
      "entities": {
        "drugs": [
          "Compound AX-17 (example)"
        ],
        "species": [
          "human"
        ],
        "conditions": [
          "Osteoarthritis"
        ],
        "mechanisms": [
          "Inflammatory pathway modulation"
        ]
      }
    },
    {
      "id": "ctgov:EXAMPLE-CKD-002",
      "source": "clinicaltrials",
      "url": "https://clinicaltrials.gov/study/NCT00000002",
      "title": "Example CKD trial (illustrative)",
      "authors": "",
      "date": "2024-08-05",
      "abstract_or_snippet": "Illustrative PK limitation summary for CKD trial.",
      "doc_type": "trial",
      "entities": {
        "drugs": [
          "Compound RN-44 (example)"
        ],
        "species": [
          "human"
        ],
        "conditions": [
          "Chronic kidney disease"
        ],
        "mechanisms": [
          "Anti-fibrotic signaling"
        ]
      }
    },
    {
      "id": "ctgov:EXAMPLE-LAM-003",
      "source": "clinicaltrials",
      "url": "https://clinicaltrials.gov/study/NCT00000003",
      "title": "Example vascular trial (illustrative)",
      "authors": "",
      "date": "2023-11-12",
      "abstract_or_snippet": "Illustrative trial design mismatch summary.",
      "doc_type": "trial",
      "entities": {
        "drugs": [
          "Compound LM-12 (example)"
        ],
        "species": [
          "human"
        ],
        "conditions": [
          "Peripheral vascular disease"
        ],
        "mechanisms": [
          "Microvascular perfusion support"
        ]
      }
    },
    {
      "id": "pmid:EXAMPLE-VET-101",
      "source": "pubmed",
      "url": "https://pubmed.ncbi.nlm.nih.gov/00000001/",
      "title": "Example canine OA case report (illustrative)",
      "authors": "",
      "date": "2024-05-01",
      "abstract_or_snippet": "Illustrative veterinary case report.",
      "doc_type": "case_report",
      "entities": {
        "drugs": [
          "Compound AX-17 (example)"
        ],
        "species": [
          "canine"
        ],
        "conditions": [
          "Osteoarthritis"
        ],
        "mechanisms": [
          "Inflammatory pathway modulation"
        ]
      }
    },
    {
      "id": "pmid:EXAMPLE-VET-202",
      "source": "pubmed",
      "url": "https://pubmed.ncbi.nlm.nih.gov/00000002/",
      "title": "Example feline CKD retrospective note (illustrative)",
      "authors": "",
      "date": "2024-03-18",
      "abstract_or_snippet": "Illustrative retrospective signal.",
      "doc_type": "review",
      "entities": {
        "drugs": [
          "Compound RN-44 (example)"
        ],
        "species": [
          "feline"
        ],
        "conditions": [
          "Chronic kidney disease"
        ],
        "mechanisms": [
          "Anti-fibrotic signaling"
        ]
      }
    },
    {
      "id": "pmid:EXAMPLE-VET-303",
      "source": "pubmed",
      "url": "https://pubmed.ncbi.nlm.nih.gov/00000003/",
      "title": "Example equine laminitis mechanistic note (illustrative)",
      "authors": "",
      "date": "2023-12-09",
      "abstract_or_snippet": "Illustrative mechanistic note for perfusion.",
      "doc_type": "review",
      "entities": {
        "drugs": [
          "Compound LM-12 (example)"
        ],
        "species": [
          "equine"
        ],
        "conditions": [
          "Laminitis"
        ],
        "mechanisms": [
          "Microvascular perfusion support"
        ]
      }
    }
  ]
}